Clinical Outcomes of MLC601 (NeuroAiD<sup>TM</sup>) in Traumatic Brain Injury: A Pilot Study

Clinical Outcomes of MLC601 (NeuroAiD<sup>TM</sup>) in Traumatic Brain Injury: A Pilot Study

Background: MLC601 is a natural product formulation from Chinese medicine that is extensively studied in ischemic stroke. Traumatic brain injury (TBI) shares pathophysiological mechanisms with ischemic stroke, yet there are few studies on the use of MLC601 in treating TBI. This Indonesian pilot stud...

Full description

Bibliographic Details
Main Authors: Asra Al Fauzi, Krisna Tsaniadi Prihastomo, I. G. M. Aswin R. Ranuh, Tedy Apriawan, Joni Wahyuhadi, M. Arifin Parenrengi, Agus Turchan, Abdul Hafid Bajamal, Hari Basuki Notobroto
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Brain Sciences
Subjects:
mlc601
traumatic brain injury
nonsurgical lesion
clinical outcome
Online Access:https://www.mdpi.com/2076-3425/10/2/60

Internet

https://www.mdpi.com/2076-3425/10/2/60

Similar Items